» Articles » PMID: 36894624

Analysis of Sequence Diversity in Plasmodium Falciparum Glutamic Acid-rich Protein (PfGARP), an Asexual Blood Stage Vaccine Candidate

Overview
Journal Sci Rep
Specialty Science
Date 2023 Mar 9
PMID 36894624
Authors
Affiliations
Soon will be listed here.
Abstract

Glutamic acid-rich protein of Plasmodium falciparum (PfGARP) binds to erythrocyte band 3 and may enhance cytoadherence of infected erythrocytes. Naturally acquired anti-PfGARP antibodies could confer protection against high parasitemia and severe symptoms. While whole genome sequencing analysis has suggested high conservation in this locus, little is known about repeat polymorphism in this vaccine candidate antigen. Direct sequencing was performed from the PCR-amplified complete PfGARP gene of 80 clinical isolates from four malaria endemic provinces in Thailand and an isolate from a Guinean patient. Publicly available complete coding sequences of this locus were included for comparative analysis. Six complex repeat (RI-RVI) and two homopolymeric glutamic acid repeat (E1 and E2) domains were identified in PfGARP. The erythrocyte band 3-binding ligand in domain RIV and the epitope for mAB7899 antibody eliciting in vitro parasite killing property were perfectly conserved across isolates. Repeat lengths in domains RIII and E1-RVI-E2 seemed to be correlated with parasite density of the patients. Sequence variation in PfGARP exhibited genetic differentiation across most endemic areas of Thailand. Phylogenetic tree inferred from this locus has shown that most Thai isolates formed closely related lineages, suggesting local expansion/contractions of repeat-encoding regions. Positive selection was observed in non-repeat region preceding domain RII which corresponded to a helper T cell epitope predicted to be recognized by a common HLA class II among Thai population. Predicted linear B cell epitopes were identified in both repeat and non-repeat domains. Besides length variation in some repeat domains, sequence conservation in non-repeat regions and almost all predicted immunogenic epitopes have suggested that PfGARP-derived vaccine may largely elicit strain-transcending immunity.

Citing Articles

Transcription and Copy Number Variation of Plasmodium falciparum var2csa among Nonpregnant Malaria Patients in Thailand.

Chaikitgosiyakul S, Kuamsab N, Tia T, Putaporntip C, Jongwutiwes S Am J Trop Med Hyg. 2024; 112(2):266-273.

PMID: 39561405 PMC: 11803657. DOI: 10.4269/ajtmh.24-0065.


Plasmodium falciparum Glutamic Acid-Rich Protein-Independent Polyclonal Antibodies Inhibit Malaria Parasite Growth in Human Erythrocytes.

Schwake C, Krueger R, Hanada T, Chishti A J Infect Dis. 2024; 229(5):1565-1573.

PMID: 38298126 PMC: 11095539. DOI: 10.1093/infdis/jiae050.


The Need for Novel Asexual Blood-Stage Malaria Vaccine Candidates for .

Takashima E, Otsuki H, Morita M, Ito D, Nagaoka H, Yuguchi T Biomolecules. 2024; 14(1).

PMID: 38254700 PMC: 10813614. DOI: 10.3390/biom14010100.

References
1.
Dorsman J, Bremmer-Bout M, Pepers B, van Ommen G, den Dunnen J . Interruption of perfect CAG repeats by CAA triplets improves the stability of glutamine-encoding repeat sequences. Biotechniques. 2002; 33(5):976-8. DOI: 10.2144/02335bm01. View

2.
Luo H, Nijveen H . Understanding and identifying amino acid repeats. Brief Bioinform. 2013; 15(4):582-91. PMC: 4103538. DOI: 10.1093/bib/bbt003. View

3.
Shimada M, Sanbonmatsu R, Yamaguchi-Kabata Y, Yamasaki C, Suzuki Y, Chakraborty R . Selection pressure on human STR loci and its relevance in repeat expansion disease. Mol Genet Genomics. 2016; 291(5):1851-69. DOI: 10.1007/s00438-016-1219-7. View

4.
Good M . Our impasse in developing a malaria vaccine. Cell Mol Life Sci. 2011; 68(7):1105-13. PMC: 11115129. DOI: 10.1007/s00018-011-0634-5. View

5.
Buppan P, Seethamchai S, Kuamsab N, Harnyuttanakorn P, Putaporntip C, Jongwutiwes S . Multiple Novel Mutations in Chloroquine Resistance Transporter Gene during Implementation of Artemisinin Combination Therapy in Thailand. Am J Trop Med Hyg. 2018; 99(4):987-994. PMC: 6159576. DOI: 10.4269/ajtmh.18-0401. View